By developing and characterizing a Neu3- and Glb1-double knockout mouse model to deplete Neu3, they found a drastically earlier onset of disease in mice, which now resembles more the infantile form of GM1 gangliosidosis in humans. Here, NEU3 is linked to GM1 gangliosidosis.